← Home
The Human Upgrade · July 9, 2026 · 0h 53m

The Foods, Drinks, and Daily Habits Wrecking Your Brain (Surprising!)

Dave Asprey and Dr. David Perlmutter discuss how microglial dysfunction and chronic inflammation may be the real drivers of Alzheimer's and Parkinson's disease, challenging the long-held amyloid hypothesis. They examine emerging treatments such as GLP-1 drugs, 40 hertz light therapy, and lifestyle interventions that target brain health. The conversation explores why decades of research focused on amyloid plaques has failed to yield effective therapies, and what new approaches offer hope.

This summary was generated from show notes and public descriptions, not from a full transcript review. Details may contain inaccuracies.

Highlights

Perlmutter explains that chronic activation of microglial cells in the brain leads to ongoing inflammation that damages neurons and underlies Alzheimer's and Parkinson's.
Emerging treatments for brain health
Asprey and Perlmutter discuss GLP-1 drugs, 40 hertz light therapy, and lifestyle interventions as innovative approaches to neurodegenerative diseases.

Contradicts

Perlmutter argues that the amyloid cascade hypothesis, which has dominated Alzheimer's research, is fundamentally flawed.
Was this useful?